Stepan Company (SCL) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally.
Total Revenue Chart for Stepan Company
Stepan Company (SCL) revenue for FY2025 was USD 2.3B, a 7.0% change from FY2024. Stepan Company's revenue grew from USD 235.9M in 1985 to USD 2.3B in 2025 (888.6% over 40 years). Earnings per share grew from USD 0.72 in 2000 to USD 2.05 in 2025 (183.2%). Revenue compound annual growth rate: 5-year CAGR of 4.5%, 10-year CAGR of 2.8%, 20-year CAGR of 3.9%.
Total Revenue (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $1.45B
- Implied Share Price
- $63.91
- Enterprise Value
- $2.04B
- Revenue (TTM)
- $2.43B
- EBITDA
- $209.64M
- Profit Margin
- -0.11%
- Trailing P/E
- —
- Forward P/E
- 17.45
- Price/Book (MRQ)
- 1.21
- Price/Sales (TTM)
- 0.60
- EV/EBITDA
- 8.98
- EV/Revenue
- 0.84
- Dividend Yield
- 2.44%
- Book Value
- $53.32
- Free Cash Flow (FY2025)
- $25.37M
- Free Cash Flow Yield
- 1.75%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.